Clinical trial

TRICuspid Intervention in Heart Failure Trial

NCT04634266

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-03-25

PhaseNA

Study timeline

Study start (actual)2022-03-25Date precision: day

Registry last updated2026-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure Attributable to Severe Tricuspid Regurgitationunresolved

Interventions

Transcatheter tricuspid valve treatment (TTVT)DEVICE

Sponsors & collaborators

LMU Klinikumlead sponsor

Heart and Diabetes Center North Rhine-Westphaliacollaborator

University Medical Center Mainzcollaborator

Heart Center Leipzig - University Hospitalcollaborator

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)collaborator

Mapped research locations

HamburgGermany3 BerlinGermany2 MünchenGermany1 EssenGermany1 LeipzigGermany1 HeidelbergGermany1 CologneGermany1 FrankfurtGermany1 MainzGermany1 UlmGermany1 DüsseldorfGermany1 BonnGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04634266 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.